These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3707514)

  • 1. Production of platelet thromboxane A2 inactivates purified human platelet thromboxane synthase.
    Hall ER; Tuan WM; Venton DL
    Biochem J; 1986 Feb; 233(3):637-41. PubMed ID: 3707514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin H2 in human platelet activation: coactivator and substitute for thromboxane A2.
    Hornberger WB; Patscheke H
    Prog Clin Biol Res; 1989; 301():315-9. PubMed ID: 2798452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate inactivation of lung thromboxane synthase preferentially decreases thromboxane A2 production.
    Hall ER; Townsend GL; Linthicum DS; Frasier-Scott KF
    Prostaglandins Leukot Essent Fatty Acids; 1991 Jan; 42(1):31-7. PubMed ID: 2011609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kinetic mechanisms of enzyme activity of the thromboxane synthetase system. Thromboxane synthetase of human platelets].
    Basevich VV; Mevkh AT; Varfolomeev SD
    Biokhimiia; 1984 Sep; 49(9):1538-45. PubMed ID: 6440597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Suicide" inactivation of thromboxane A2 synthase. Characteristics of mechanism-based inactivation with isolated enzyme and intact platelets.
    Jones DA; Fitzpatrick FA
    J Biol Chem; 1990 Nov; 265(33):20166-71. PubMed ID: 2243085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet rich plasma transforms exogenous prostaglandin endoperoxide H2 into thromboxane A2.
    Fitzpatrick FA; Gorman RR
    Prostaglandins; 1977 Nov; 14(5):881-9. PubMed ID: 594390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism-based inactivation of thromboxane A2 synthase.
    Fitzpatrick FA; Jones D; Winitz S; Fish HT
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():161-3. PubMed ID: 1825535
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
    Vezza R; Mezzasoma AM; Venditti G; Gresele P
    Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolution of prostaglandin endoperoxide synthase and thromboxane synthase of human platelets.
    Hammarström S; Falardeau P
    Proc Natl Acad Sci U S A; 1977 Sep; 74(9):3691-5. PubMed ID: 410024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of thromboxane A2/prostaglandin H2 receptors of various tissues using a new radioiodinated thromboxane A2/prostaglandin H2 mimetic, I-BOP.
    Morinelli TA; Naka M; Masuda A; Oatis JE; Okwu AK; Mais DE; Saussy DL; Halushka PV
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():331-7. PubMed ID: 1825565
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolation and characterization of thromboxane synthase from human platelets as a cytochrome P-450 enzyme.
    Haurand M; Ullrich V
    J Biol Chem; 1985 Dec; 260(28):15059-67. PubMed ID: 2999104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboxane-induced phosphatidate formation in human platelets. Relationship to receptor occupancy and to changes in cytosolic free calcium.
    Pollock WK; Armstrong RA; Brydon LJ; Jones RL; MacIntyre DE
    Biochem J; 1984 May; 219(3):833-42. PubMed ID: 6234886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic studies on the conversion of prostaglandin endoperoxide PGH2 by thromboxane synthase.
    Anderson MW; Crutchley DJ; Tainer BE; Eling TE
    Prostaglandins; 1978 Oct; 16(4):563-70. PubMed ID: 725086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient concentrations and agonist potency of PGH2 in platelet activation by endogenous arachidonate.
    Hornberger W; Patscheke H
    Eicosanoids; 1989; 2(4):241-8. PubMed ID: 2517034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary vascular responses to thromboxane A2 as unmasked by OKY-1581. A novel inhibitor of thromboxane synthesis.
    Kadowitz PJ; Nandiwada PA; Spannhake EW; Rosenson RS; McNamara DB; Hyman AL
    Chest; 1983 May; 83(5 Suppl):72S-74S. PubMed ID: 6404609
    [No Abstract]   [Full Text] [Related]  

  • 16. Biosynthesis and pharmacological modulation of thromboxane in humans.
    Patrono C
    Circulation; 1990 Jan; 81(1 Suppl):I12-5; discussion I22-3. PubMed ID: 2136814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
    Vezza R; Nenci GG; Gresele P
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitisation of human platelets against stimulation by thromboxane mimics--reduction in receptor capacity and loss of functional response.
    Thierauch KH; Gabriel D; Prior G; Schillinger E
    Biomed Biochim Acta; 1988; 47(10-11):S75-8. PubMed ID: 2470362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photoaffinity labelling of the human platelet thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptor.
    Mais DE; Halushka PV
    Prog Clin Biol Res; 1989; 301():303-7. PubMed ID: 2529550
    [No Abstract]   [Full Text] [Related]  

  • 20. Immobilization of catalytically active thromboxane synthase.
    Hall ER; Townsend GL; Tuan WM; Venton DL
    Prostaglandins Leukot Essent Fatty Acids; 1988 May; 32(2):51-6. PubMed ID: 3406040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.